Infuse Multifocal
Payments companies reported to CMS as associated with Infuse Multifocal. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Infuse Multifocal, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Infuse Multifocal
These are the largest totals companies reported as associated with Infuse Multifocal. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Womack | Canton, GA | Optometrist | $49,019.52 |
| Osama Said | Raleigh, NC | Optometrist | $41,912.46 |
| Ryan Corte | Asheville, NC | Optometrist | $31,524.28 |
| Katie Chu | Rosemead, CA | Optometrist | $30,124.89 |
| Jason Tu | San Diego, CA | Optometrist | $26,471.69 |
| Scott Moscow | Roswell, GA | Optometrist | $26,173.27 |
| James Hoffman | Orange Park, FL | Optometrist | $24,564.43 |
| Roy Kline | Lake Katrine, NY | Optometrist | $24,552.46 |
| Brad Laudicina | Bradenton, FL | Optometrist | $22,778.67 |
| Mark Schaeffer | Hoover, AL | Optometrist | $20,166.02 |
Prescribed Infuse Multifocal?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.